Logo
x

Search

Subscribe Now

juvenile idiopathic arthritis

Innovent's Sulinno (biosimilar- adalimumab) Receive NMPA's Approval for Polyarticular Juvenile Idiopathic Arthritis

Innovent's Sulinno (biosimilar- adalimumab) Receive NMPA's Approval for Polyarticular Juvenile Idiopathic Arthritis

  • November 23, 2020
Merck's Brenzys (etanercept- biosimilar) Receives Health Canada Approval for Multiple Indications

Merck's Brenzys (etanercept- biosimilar) Receives Health Canada Approval for Multiple Indications

  • September 16, 2020
Cadila to Launch its Cadalimab (biosimilar- adalimumab) in India

Cadila to Launch its Cadalimab (biosimilar- adalimumab) in India

  • August 28, 2020
Lupin and Mylan Launch Nepexto (biosimilar- etanercept) in Germany

Lupin and Mylan Launch Nepexto (biosimilar- etanercept) in Germany

  • August 27, 2020
PharmaShots' Key Highlights of First Quarter 2019

PharmaShots' Key Highlights of First Quarter 2019

  • August 4, 2019
Lupin and YL Biologics' Etanercept Biosimilar (YLB113) Receive PMDA's Approval for Moderate-to-Severe Rheumatoid Arthritis (RA) and Juvenile Idiopathic Arthritis (JIA) in Japan

Lupin and YL Biologics' Etanercept Biosimilar (YLB113) Receive PMDA's Approval for Moderate-to-Severe Rheumatoid Arthritis (RA) an...

  • March 26, 2019
Insights+ Key Biosimilars Events of October 2023

    Insights+ Key Biosimilars Events of October 2023

    • November 1, 2023
    Boehringer Ingelheim Reports the Commercial Availability of Humira Biosimilar

      Boehringer Ingelheim Reports the Commercial Availability of Humira Biosimilar

      • October 2, 2023
      Celltrion Launches Yuflyma (biosimilar, adalimumab) in the US

        Celltrion Launches Yuflyma (biosimilar, adalimumab) in the US

        • July 4, 2023
        Coherus Launches Yusimry (biosimilar, adalimumab) in the US at 85% Discount

          Coherus Launches Yusimry (biosimilar, adalimumab) in the US at 85% Discount

          • July 3, 2023
          Sandoz to Launch Hyrimoz High-Concentration Formulation Biosimilar in the US

            Sandoz to Launch Hyrimoz High-Concentration Formulation Biosimilar in the US

            • July 1, 2023
            Top Performing Drug – Enbrel (June Edition)

              Top Performing Drug – Enbrel (June Edition)

              • June 28, 2023
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.